4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-006138
VP Clinical Reg Affairs bought 250 shares at $15.40 ($3,849)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thompson Jaye VP Clinical Reg Affairs | 2023-02-24 | Purchase | +250 | $15.40 | $3,849 | 257,495 | D |
| Open-market purchases · 250 sh · avg $15.40 · $3,849 | |||||||
Loading xslF345X03/ownership.xml…